Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy
derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course …
derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course …
Blastic plasmacytoid dendritic cell neoplasm: state of the art and prospects
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare tumour, which
usually affects elderly males and presents in the skin with frequent involvement of the bone …
usually affects elderly males and presents in the skin with frequent involvement of the bone …
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis
Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by fibrosis and
vasculopathy. CXCL4 represents an early serum biomarker of severe SSc and likely …
vasculopathy. CXCL4 represents an early serum biomarker of severe SSc and likely …
Dual expression of TCF4 and CD123 is highly sensitive and specific for blastic plasmacytoid dendritic cell neoplasm
The diagnosis of blastic plasmacytoid dendritic cell neoplasm (BPDCN) has been based on
the expression status of multiple markers, including CD123. TCF4 was discovered recently …
the expression status of multiple markers, including CD123. TCF4 was discovered recently …
Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a ten-color flow cytometric panel for initial workup …
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematopoietic neoplasm
whose immunophenotype remains incompletely characterized, particularly with regards to …
whose immunophenotype remains incompletely characterized, particularly with regards to …
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow
K Alayed, KP Patel, S Konoplev… - American journal of …, 2013 - Wiley Online Library
Distinguishing blastic plasmacytoid dendritic cell neoplasm (BPDCN) from acute myeloid
leukemia (AML) is gaining increased importance because of emerging differences in …
leukemia (AML) is gaining increased importance because of emerging differences in …
Transcriptional control of dendritic cell development and functions
L Amon, CHK Lehmann, A Baranska, J Schoen… - International review of …, 2019 - Elsevier
Dendritic cells (DCs) are major regulators of adaptive immunity, as they are not only capable
to induce efficient immune responses, but are also crucial to maintain peripheral tolerance …
to induce efficient immune responses, but are also crucial to maintain peripheral tolerance …
[HTML][HTML] Neoplasms derived from plasmacytoid dendritic cells
F Facchetti, M Cigognetti, S Fisogni, G Rossi… - Modern Pathology, 2016 - Elsevier
Plasmacytoid dendritic cell neoplasms manifest in two clinically and pathologically distinct
forms. The first variant is represented by nodular aggregates of clonally expanded …
forms. The first variant is represented by nodular aggregates of clonally expanded …
Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection
ZJ Zhou, HY **n, J Li, ZQ Hu, CB Luo… - Cancer Immunology …, 2019 - Springer
Plasmacytoid dendritic cells (pDCs) are present in various primary and metastatic human
neoplasms; however, their clinical significance in hepatocellular carcinoma (HCC) is …
neoplasms; however, their clinical significance in hepatocellular carcinoma (HCC) is …
Blastic plasmacytoid dendritic cell neoplasm–current insights
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare clonal hematologic
malignancy of plasmacytoid dendritic cell precursors. The presentation and clinical course of …
malignancy of plasmacytoid dendritic cell precursors. The presentation and clinical course of …